The Scientist - Home

The results from two Phase 1 trials bolster the case that the gut microbiome plays a role in response to the drugs.

A study proposes that habitat for bats—and their accompanying coronaviruses—has increased in southern Asia over the last century, but experts debate the reliability of the analysis.

Directing an object on a screen to a target provided a tasty reward.

Using CRISPR to swap an archaic variant of the NOVA1 gene into human stem cells, researchers create organoids with neurodevelopmental differences from those carrying modern DNA.

The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.

The review of more than two dozen studies finds aripiprazole has side effects and does not change core autism features, but parents report improvements in self-injury, tantrums, and other challenging behaviors.

Listen to a musicologist blow through the oldest known shell horn.

Preliminary results from an Israel-based study suggest that one dose of the vaccine reduces infectiousness—a key factor in slowing virus spread.

An investigation by the World Health Organization into the origins of COVID-19 will instead focus on the virus’s animal origins and the possibility of spread through frozen foods.

The Trump-era regulation, which allowed certain studies to be downplayed in the development of environmental regulations, drew sharp criticism from scientists and environmental groups.

While studying a degenerative eye disease, researchers find the first evidence that cells produce endogenous DNA in the cytoplasm. Drugs that block this activity are linked with reduced risk of atrophic age-related macular degeneration.

Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them.